The cytokine profile of women with severe anxiety and depression during pregnancy

BMC Psychiatry

Volumn 19, Issue 1, 2019, Pages

  Leff Gelman, P ^a   Mancilla Herrera, I ^c   Flores Ramos, M ^b,f   Saravia Takashima, M F ^c   Cruz Coronel, F M ^c   Cruz Fuentes, C ^b   Perez Molina A ^b   Hernandez Ruiz J ^d   Silva Aguilera, F S ^d   Farfan Labonne, B ^a   Chinchilla Ochoa, D ^a   Garza Morales, S ^a   Camacho Arroyo, I ^e  

^a Isidro Espinosa de Los Reyes   (Mexico)

^b INSTITUTO NACIONAL DE PSIQUIATRÍA RAMÓN DE LA FUENTE MUÑIZ   (Mexico)

^c HOSPITAL GENERAL DE MÉXICO   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^f Unidad Durango   (Mexico)

Author keywords

Anxiety; Cytokines; Depression; Inflammation; Pregnancy

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 22; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 9; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ANXIETY; ARTICLE; CONCENTRATION (PARAMETER); CONTROLLED STUDY; CORRELATIONAL STUDY; DEPENDENT VARIABLE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HAMILTON ANXIETY SCALE; HAMILTON DEPRESSION RATING SCALE; HUMAN; INDEPENDENT VARIABLE; LINEAR SYSTEM; MAJOR CLINICAL STUDY; MATERNAL DISEASE; MULTIPLEX BEAD BASED ASSAY; PREGNANCY; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; TH1 CELL; TH17 CELL; TH2 CELL; THIRD TRIMESTER PREGNANCY; ANXIETY DISORDER; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; PREGNANCY COMPLICATION; PREGNANT WOMAN; YOUNG ADULT;

ADULT; ANXIETY; ANXIETY DISORDERS; CASE-CONTROL STUDIES; CYTOKINES; DEPRESSION; FEMALE; HUMANS; INTERLEUKIN-10; INTERLEUKIN-17; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANT WOMEN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 85063930923     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/s12888-019-2087-6     Document Type: Article

References (48)

1. Dowlati Y, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446-57.
2. Kopschina Feltes P, et al. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149-65.
3. Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732-41.
4. Rush AJ, et al. Sequenced treatment alternatives to relieve depression (STAR∗D): rationale and design. Control Clin Trials. 2004;25(1):119-42.
5. Leff-Gelman P, et al. The immune system and the role of inflammation in perinatal depression. Neurosci Bull. 2016;32(4):398-420.
6. Cheng CY, Pickler RH. Perinatal stress, fatigue, depressive symptoms, and immune modulation in late pregnancy and one month postpartum. ScientificWorldJournal. 2014;2014:652630.
7. Marcus SM, et al. Depressive symptoms among pregnant women screened in obstetrics settings. J Women's Health (Larchmt). 2003;12(4):373-80.
8. Bittner A, et al. Early intervention in pregnant women with elevated anxiety and depressive symptoms: efficacy of a cognitive-behavioral group program. J Perinat Neonatal Nurs. 2014;28(3):185-95.
9. Stuart-Parrigon K, Stuart S. Perinatal depression: an update and overview. Curr Psychiatry Rep. 2014;16(9):468.
10. Dayan J, et al. Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort study among women with early and regular care. Psychosom Med. 2006;68(6):938-46.
11. Pakenham KI, Smith A, Rattan SL. Application of a stress and coping model to antenatal depressive symptomatology. Psychol Health Med. 2007;12(3):266-77.
12. Fairbrother N, et al. Psychometric evaluation of the multidimensional assessment of fatigue scale for use with pregnant and postpartum women. Psychol Assess. 2008;20(2):150-8.
13. Chien LY, Ko YL. Fatigue during pregnancy predicts caesarean deliveries. J Adv Nurs. 2004;45(5):487-94.
14. Field T, Diego M, Hernandez-Reif M. Prenatal depression effects on the fetus and newborn: a review. Infant Behav Dev. 2006;29(3):445-55.
15. Piccinni MP. T cell tolerance towards the fetal allograft. J Reprod Immunol. 2010;85(1):71-5.
16. Meltzer-Brody S. New insights into perinatal depression: pathogenesis and treatment during pregnancy and postpartum. Dialogues Clin Neurosci. 2011;13(1):89-100.
17. Saito S, et al. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am J Reprod Immunol. 2010;63(6):601-10.
18. Mastorakos G, Ilias I. Maternal and fetal hypothalamic-pituitary-adrenal axes during pregnancy and postpartum. Ann N Y Acad Sci. 2003;997:136-49.
19. Rosenblat JD, et al. Inflamed moods: a review of the interactions between inflammation and mood disorders. Prog Neuro-Psychopharmacol Biol Psychiatry. 2014;53:23-34.
20. Wohleb ES, et al. Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology. 2012;37(9):1491-505.
21. Wohleb ES, et al. Beta-adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci. 2011;31(17):6277-88.
22. Czeh M, Gressens P, Kaindl AM. The yin and yang of microglia. Dev Neurosci. 2011;33(3-4):199-209.
23. Venneti S, Lopresti BJ, Wiley CA. Molecular imaging of microglia/macrophages in the brain. Glia. 2013;61(1):10-23.
24. Glynn LM, et al. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol. 2008;27(1):43.
25. Hobel CJ, Goldstein A, Barrett ES. Psychosocial stress and pregnancy outcome. Clin Obstet Gynecol. 2008;51(2):333-48.
26. Latendresse G. The interaction between chronic stress and pregnancy: preterm birth from a biobehavioral perspective. J Midwifery Womens Health. 2009;54(1):8-17.
27. Latendresse G, Ruiz RJ, Wong B. Psychological distress and SSRI use predict variation in inflammatory cytokines during pregnancy. Open J Obstet Gynecol. 2013;3(1A):184.
28. Christian LM, et al. Depressive symptoms are associated with elevated serum proinflammatory cytokines among pregnant women. Brain Behav Immun. 2009;23(6):750-4.
29. Simpson W, et al. Relationship between inflammatory biomarkers and depressive symptoms during late pregnancy and the early postpartum period: a longitudinal study. Rev Bras Psiquiatr. 2016;38(3):190-6.
30. Karlsson L, et al. Cytokine profile and maternal depression and anxiety symptoms in mid-pregnancy - the FinnBrain birth cohort study. Arch Womens Ment Health. 2017;20(1):39-48.
31. Dantzer R, et al. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46.
32. O'Donovan A, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion-biology relationships. Brain Behav Immun. 2010;24(7):1074-7.
33. Field T. Prenatal anxiety effects: a review. Infant Behav Dev. 2017;49:120-8.
34. Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50-5.
35. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
36. Ramos-Brieva JA, Cordero-Villafafila A. A new validation of the Hamilton rating scale for depression. J Psychiatr Res. 1988;22(1):21-8.
37. Lobo A, et al. Validation of the Spanish versions of the Montgomery-Asberg depression and Hamilton anxiety rating scales. Med Clin (Barc). 2002;118(13):493-9.
38. Maier W, et al. The Hamilton anxiety scale: reliability, validity and sensitivity to change in anxiety and depressive disorders. J Affect Disord. 1988;14(1):61-8.
39. Snegovskikh V, Park JS, Norwitz ER. Endocrinology of parturition. Endocrinol Metab Clin N Am. 2006;35(1):173-91 viii.
40. Coussons-Read ME, Okun ML, Nettles CD. Psychosocial stress increases inflammatory markers and alters cytokine production across pregnancy. Brain Behav Immun. 2007;21(3):343-50.
41. Raison CL. Inflammatory depression: a trifecta of trouble. J Clin Psychiatry. 2014;75(6):663-4.
42. Coussons-Read ME, et al. Prenatal stress alters cytokine levels in a manner that may endanger human pregnancy. Psychosom Med. 2005;67(4):625-31.
43. Hu Y, Huang K. Placenta response of inflammation and oxidative stress in low-risk term childbirth: the implication of delivery mode. BMC Pregnancy and Childbirth. 2017;17(1):407.
44. Baker DG, Nievergelt CM, O'Connor DT. Biomarkers of PTSD: neuropeptides and immune signaling. Neuropharmacology. 2012;62(2):663-73.
45. Osborne LM, et al. Innate immune activation and depressive and anxious symptoms across the peripartum: an exploratory study. Psychoneuroendocrinology. 2019;99:80-6.
46. Goswami R, Kaplan MH. A brief history of IL-9. J Immunol. 2011;186(6):3283-8.
47. Guéry L, Hugues S. Th17 cell plasticity and functions in cancer immunity. Biomed Res Int. 2015;2015.
48. Hou R, et al. Peripheral inflammatory cytokines and immune balance in generalised anxiety disorder: case-controlled study. Brain Behav Immun. 2017;62:212-8.